Seeing Is Believing
Currently out of the existing stock ratings of Ashwani Verma, 28 are a BUY (68.29%), 10 are a HOLD (24.39%), 3 are a SELL (7.32%).
Analyst Ashwani Verma works at UBS with a stock forecast success ratio of 57.74% fulfilled within 129.14 days on average.
Ashwani Verma’s has documented 82 price targets and ratings displayed on 14 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on JAZZ, Jazz Pharmaceuticals PLC at 01-Mar-2024.
Analyst best performing recommendations are on RANI (RANI THERAPEUTICS HOLDINGS).
The best stock recommendation documented was for RANI (RANI THERAPEUTICS HOLDINGS) at 11/15/2023. The price target of $4 was fulfilled within 146 days with a profit of $2.01 (101.01%) receiving and performance score of 6.92.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
120
$47.27 (64.99%)
101
8 days ago
14/24 (58.33%)
$46.88 (64.11%)
560
Buy
107
$34.27 (47.12%)
100
9 days ago
2/11 (18.18%)
$32.99 (44.58%)
606
Buy
96
$23.27 (32.00%)
82
10 days ago
7/9 (77.78%)
$21.46 (28.79%)
312
Buy
90
$17.27 (23.75%)
82
10 days ago
14/17 (82.35%)
$15.46 (20.74%)
161
Hold
77
$4.27 (5.87%)
64
15 days ago
4/6 (66.67%)
$0.31 (0.40%)
181
Which stock is Ashwani Verma is most bullish on?
Which stock is Ashwani Verma is most reserved on?
What Year was the first public recommendation made by Ashwani Verma?